BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30
• 31

• Drug Development

  New Canine Study From Belhaven Biopharma Supports Dry Powder Nasal Epinephrine Delivery Solution

  July 10, 2024

   · 

  4 min read
• News

  Signature Orthopaedics Collaborates with THINK Surgical for Robotic TKA

  July 10, 2024

   · 

  2 min read
• Business

  Trinity Biotech Announces Appointment of A New CFO

  July 10, 2024

   · 

  5 min read
• Business

  ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2024

  July 10, 2024

   · 

  6 min read
• Business

  Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - July 09, 2024

  July 10, 2024

   · 

  1 min read
• Business

  Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - July 09, 2024

  July 10, 2024

   · 

  2 min read
• Business

  Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - July 09, 2024

  July 10, 2024

   · 

  3 min read
• Drug Development

  Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical development stage, highly selective third generation RXR nuclear receptor agonist compound, supporting its potential use for prevention and treatment of normal aging-related neurodegeneration, Parkinson’s disease, and Alzheimer’s disease

  July 10, 2024

   · 

  5 min read
• Drug Development

  Evotec and Pfizer Collaborate to Advance Drug Discovery in France

  July 10, 2024

   · 

  4 min read
• Business

  HepaRegeniX raises €15 million Series C round to advance clinical development of HRX-215 for liver regeneration

  July 10, 2024

   · 

  4 min read